115 related articles for article (PubMed ID: 3602022)
21. [Use of Trental in the treatment of arterial and venous circulation disorders].
Grujić M; Obradov S; Perinović M; Rizvanbegović B
Med Arh; 1976; 30(5):327-30. PubMed ID: 798077
[No Abstract] [Full Text] [Related]
22. [Therapeutic results with xanthine derivatives in the intermittent claudication syndrome in diabetic patients].
Gómez Reyes D; Rojas Hidalgo E
Rev Clin Esp; 1988 Jan; 182(1):3-6. PubMed ID: 3375512
[No Abstract] [Full Text] [Related]
23. Cerebral blood flow in patients with cerebrovascular disorders: study with pentoxifylline.
Hartmann A
Ric Clin Lab; 1981; 11 Suppl 1():243-6. PubMed ID: 7188111
[TBL] [Abstract][Full Text] [Related]
24. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
25. Studies on the vasoocclusive crisis of sickle cell disease IV. Mechanism of action of pentoxifylline (Trental).
Ambrus JL; Meky N; Stadler S; Sills RH; Gastpar H; Raposa T
J Med; 1988; 19(2):67-88. PubMed ID: 3171402
[TBL] [Abstract][Full Text] [Related]
26. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
[TBL] [Abstract][Full Text] [Related]
27. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ
Angiology; 1989 Jul; 40(7):639-49. PubMed ID: 2662830
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and clinical tolerance of parenteral pentoxifylline in the treatment of critical lower limb ischemia. A placebo controlled multicenter study. Norwegian Pentoxifylline Multicenter Trial Group.
Int Angiol; 1996 Mar; 15(1):75-80. PubMed ID: 8739541
[TBL] [Abstract][Full Text] [Related]
29. Clinical considerations and treatment of diabetic angiopathy.
Nobbe F
J Med; 1979; 10(5):365-79. PubMed ID: 393791
[No Abstract] [Full Text] [Related]
30. [Drug therapy of arterial diseases. A study with Trental 400].
Tannenberg G
Fortschr Med; 1980 Dec; 98(45):1795-8. PubMed ID: 7461576
[TBL] [Abstract][Full Text] [Related]
31. Dose-response effects of pentoxifylline on erythrocyte filterability: clinical and animal model studies.
Ambrus JL; Anain JM; Anain SM; Anain PM; Anain JM; Stadler S; Mitchell P; Brobst JA; Cobert BL; Savitsky JP
Clin Pharmacol Ther; 1990 Jul; 48(1):50-6. PubMed ID: 2196145
[TBL] [Abstract][Full Text] [Related]
32. [Clinical study of the cerebrovascular action of pentoxifylline].
Shtok VN; Fedorova NV; Gadanova IV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):60-6. PubMed ID: 7064607
[TBL] [Abstract][Full Text] [Related]
33. Study on relationship between erythrocyte filtration and other risk factors in diabetic angiopathy.
Pozza G; Cordaro C; Carandente O; Margonato A
Ric Clin Lab; 1981; 11 Suppl 1():317-26. PubMed ID: 7188119
[TBL] [Abstract][Full Text] [Related]
34. [Parenteral pentoxifylline treatment of ischemic cerebrovascular accident. Preliminary results].
Schneider R; Kiesewetter H
Dtsch Med Wochenschr; 1982 Nov; 107(44):1674-7. PubMed ID: 7140544
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic effect of Trental in diabetic angiopathy].
Pampulov L; Kolarov P; Veleva N
Vutr Boles; 1978; 17(2):66-72. PubMed ID: 349882
[TBL] [Abstract][Full Text] [Related]
36. Clinical investigation of the effects of pentoxifylline in patients with severe peripheral occlusive vascular disease.
Sternitzky R; Seige K
Curr Med Res Opin; 1985; 9(9):602-10. PubMed ID: 4053674
[TBL] [Abstract][Full Text] [Related]
37. Diabetic retinal vascular complications and erythrocyte filtrability; results of a 2-year follow-up study with pentoxifylline.
Solerte SB; Ferrari E
Pharmatherapeutica; 1985; 4(6):341-50. PubMed ID: 4080752
[TBL] [Abstract][Full Text] [Related]
38. [Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)].
von Westphalen JG
MMW Munch Med Wochenschr; 1977 Jul; 119(26):901-4. PubMed ID: 408616
[TBL] [Abstract][Full Text] [Related]
39. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
Pilla G; Ciaponi A; Migliavacca A; Bonora C
Ric Clin Lab; 1983; 13 Suppl 3():459-64. PubMed ID: 6324325
[TBL] [Abstract][Full Text] [Related]
40. Red cell deformability in patients with chronic atheromatous ischemia of the legs.
Drozdz W; Panek J; Lejman W
Med Sci Monit; 2001; 7(5):933-9. PubMed ID: 11535938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
